annual CFO:
-$170.00M+$136.00M(+44.44%)Summary
- As of today (September 16, 2025), RCUS annual cash flow from operations is -$170.00 million, with the most recent change of +$136.00 million (+44.44%) on December 31, 2024.
- During the last 3 years, RCUS annual CFO has risen by +$86.00 million (+33.59%).
- RCUS annual CFO is now -138.81% below its all-time high of $438.00 million, reached on December 31, 2022.
Performance
RCUS Cash from operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFO:
-$133.00M-$1.00M(-0.76%)Summary
- As of today (September 16, 2025), RCUS quarterly cash flow from operations is -$133.00 million, with the most recent change of -$1.00 million (-0.76%) on June 30, 2025.
- Over the past year, RCUS quarterly CFO has dropped by -$39.00 million (-41.49%).
- RCUS quarterly CFO is now -120.34% below its all-time high of $654.00 million, reached on March 31, 2022.
Performance
RCUS quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFO:
-$339.00M-$39.00M(-13.00%)Summary
- As of today (September 16, 2025), RCUS TTM cash flow from operations is -$339.00 million, with the most recent change of -$39.00 million (-13.00%) on June 30, 2025.
- Over the past year, RCUS TTM CFO has dropped by -$92.00 million (-37.25%).
- RCUS TTM CFO is now -171.62% below its all-time high of $473.31 million, reached on June 30, 2022.
Performance
RCUS TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
RCUS Cash from operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +44.4% | -41.5% | -37.3% |
| 3 y3 years | +33.6% | -104.6% | -171.6% |
| 5 y5 years | -131.4% | -455.6% | -268.1% |
RCUS Cash from operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -138.8% | +44.4% | -611.5% | at low | -171.6% | at low |
| 5 y | 5-year | -138.8% | +44.4% | -120.3% | at low | -171.6% | at low |
| alltime | all time | -138.8% | +44.4% | -120.3% | at low | -171.6% | at low |
RCUS Cash from operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$133.00M(+0.8%) | -$339.00M(+13.0%) |
| Mar 2025 | - | -$132.00M(+32.0%) | -$300.00M(+76.5%) |
| Dec 2024 | -$170.00M(-44.4%) | -$100.00M(-484.6%) | -$170.00M(+7.6%) |
| Sep 2024 | - | $26.00M(-127.7%) | -$158.00M(-36.0%) |
| Jun 2024 | - | -$94.00M(+4600.0%) | -$247.00M(+17.6%) |
| Mar 2024 | - | -$2.00M(-97.7%) | -$210.00M(-31.4%) |
| Dec 2023 | -$306.00M(-169.9%) | -$88.00M(+39.7%) | -$306.00M(+6.3%) |
| Sep 2023 | - | -$63.00M(+10.5%) | -$288.00M(-5.9%) |
| Jun 2023 | - | -$57.00M(-41.8%) | -$306.00M(-2.5%) |
| Mar 2023 | - | -$98.00M(+40.0%) | -$314.00M(-171.7%) |
| Dec 2022 | $438.00M(-271.1%) | -$70.00M(-13.6%) | $438.00M(-1.8%) |
| Sep 2022 | - | -$81.00M(+24.6%) | $446.07M(-5.8%) |
| Jun 2022 | - | -$65.00M(-109.9%) | $473.31M(+1.9%) |
| Mar 2022 | - | $654.00M(-1156.0%) | $464.32M(-281.4%) |
| Dec 2021 | -$256.00M | -$61.93M(+15.2%) | -$256.00M(+4.9%) |
| Sep 2021 | - | -$53.76M(-27.4%) | -$244.12M(-1042.4%) |
| Jun 2021 | - | -$74.00M(+11.6%) | $25.90M(-65.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2021 | - | -$66.32M(+32.5%) | $75.96M(-31.6%) |
| Dec 2020 | $111.00M(-251.1%) | -$50.05M(-123.1%) | $111.00M(-26.8%) |
| Sep 2020 | - | $216.26M(-1003.4%) | $151.58M(-264.6%) |
| Jun 2020 | - | -$23.94M(-23.5%) | -$92.08M(+4.8%) |
| Mar 2020 | - | -$31.28M(+230.2%) | -$87.90M(+19.7%) |
| Dec 2019 | -$73.46M(+70.9%) | -$9.47M(-65.4%) | -$73.46M(+3.3%) |
| Sep 2019 | - | -$27.40M(+38.7%) | -$71.10M(+28.2%) |
| Jun 2019 | - | -$19.75M(+17.3%) | -$55.46M(+19.1%) |
| Mar 2019 | - | -$16.84M(+136.9%) | -$46.59M(+8.4%) |
| Dec 2018 | -$43.00M(+71.6%) | -$7.11M(-39.6%) | -$43.00M(+111.8%) |
| Sep 2018 | - | -$11.77M(+8.2%) | -$20.30M(-38.0%) |
| Jun 2018 | - | -$10.88M(-17.9%) | -$32.77M(+14.1%) |
| Mar 2018 | - | -$13.25M(-185.0%) | -$28.71M(+14.6%) |
| Dec 2017 | -$25.06M(+93.6%) | $15.59M(-164.3%) | -$25.06M(-38.3%) |
| Sep 2017 | - | -$24.23M(+255.6%) | -$40.65M(+147.7%) |
| Jun 2017 | - | -$6.82M(-29.0%) | -$16.41M(+71.0%) |
| Mar 2017 | - | -$9.60M | -$9.60M |
| Dec 2016 | -$12.94M | - | - |
FAQ
- What is Arcus Biosciences, Inc. annual cash flow from operations?
- What is the all time high annual CFO for Arcus Biosciences, Inc.?
- What is Arcus Biosciences, Inc. annual CFO year-on-year change?
- What is Arcus Biosciences, Inc. quarterly cash flow from operations?
- What is the all time high quarterly CFO for Arcus Biosciences, Inc.?
- What is Arcus Biosciences, Inc. quarterly CFO year-on-year change?
- What is Arcus Biosciences, Inc. TTM cash flow from operations?
- What is the all time high TTM CFO for Arcus Biosciences, Inc.?
- What is Arcus Biosciences, Inc. TTM CFO year-on-year change?
What is Arcus Biosciences, Inc. annual cash flow from operations?
The current annual CFO of RCUS is -$170.00M
What is the all time high annual CFO for Arcus Biosciences, Inc.?
Arcus Biosciences, Inc. all-time high annual cash flow from operations is $438.00M
What is Arcus Biosciences, Inc. annual CFO year-on-year change?
Over the past year, RCUS annual cash flow from operations has changed by +$136.00M (+44.44%)
What is Arcus Biosciences, Inc. quarterly cash flow from operations?
The current quarterly CFO of RCUS is -$133.00M
What is the all time high quarterly CFO for Arcus Biosciences, Inc.?
Arcus Biosciences, Inc. all-time high quarterly cash flow from operations is $654.00M
What is Arcus Biosciences, Inc. quarterly CFO year-on-year change?
Over the past year, RCUS quarterly cash flow from operations has changed by -$39.00M (-41.49%)
What is Arcus Biosciences, Inc. TTM cash flow from operations?
The current TTM CFO of RCUS is -$339.00M
What is the all time high TTM CFO for Arcus Biosciences, Inc.?
Arcus Biosciences, Inc. all-time high TTM cash flow from operations is $473.31M
What is Arcus Biosciences, Inc. TTM CFO year-on-year change?
Over the past year, RCUS TTM cash flow from operations has changed by -$92.00M (-37.25%)